Yi-ping C. Hung

No. 201, Sec. 2, Shipai Rd
Beitou, TPQ 11217, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 76 publications

Adjuvant chemoradiotherapy for stage III gastric cancer: A differential role in R0 and non-R0 resection.

Adjuvant chemoradiotherapy for stage III gastric cancer: A differential role in R0 and non-R0 resection.

Journal: Journal of the Chinese Medical Association : JCMA

Published: December 30, 2025

A Multinational, Retrospective, Real-World Study: Treatment Patterns in Patients With HER2-Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Beyond First-line in East Asia (HER2+ GASTA Study).

A Multinational, Retrospective, Real-World Study: Treatment Patterns in Patients With HER2-Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Beyond First-line in East Asia (HER2+ GASTA Study).

Journal: Cancer research and treatment

Published: December 05, 2025

Taiwan liver cancer association management consensus guidelines for intermediate-stage hepatocellular carcinoma.

Taiwan liver cancer association management consensus guidelines for intermediate-stage hepatocellular carcinoma.

Journal: Clinical and molecular hepatology

Published: July 03, 2025

Carbon ion therapy for pancreatic cancer with risk-adapted dose escalation: initial clinical experience.

Carbon ion therapy for pancreatic cancer with risk-adapted dose escalation: initial clinical experience.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: June 18, 2025

Surgical Resection after Chemoradiotherapy with a Higher Radiation Dose in Locally Advanced Esophageal Cancer: A Retrospective Study from Taiwan.

Surgical Resection after Chemoradiotherapy with a Higher Radiation Dose in Locally Advanced Esophageal Cancer: A Retrospective Study from Taiwan.

Journal: Journal of chest surgery

Published: April 21, 2025

Characteristics and prognosis of skip lymph node metastasis in gastric cancer: a retrospective study.

Characteristics and prognosis of skip lymph node metastasis in gastric cancer: a retrospective study.

Journal: World journal of surgical oncology

Published: March 03, 2025

Efficacy of neoadjuvant chemoradiotherapy with 5-fluorouracil/cisplatin versus paclitaxel/cisplatin in esophageal squamous cell carcinoma: A single-institute real-world study.

Efficacy of neoadjuvant chemoradiotherapy with 5-fluorouracil/cisplatin versus paclitaxel/cisplatin in esophageal squamous cell carcinoma: A single-institute real-world study.

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: February 11, 2025

Comparative impact of tertiary lymphoid structures and tumor-infiltrating lymphocytes in cholangiocarcinoma.

Comparative impact of tertiary lymphoid structures and tumor-infiltrating lymphocytes in cholangiocarcinoma.

Journal: Journal for immunotherapy of cancer

Published: January 01, 2025

Editorial: High Baseline ALT Level Confers Risk of Hepatic Adverse Events During Immune Checkpoint Inhibitors Treatment: A Call for Caution-Authors' Reply.

Editorial: High Baseline ALT Level Confers Risk of Hepatic Adverse Events During Immune Checkpoint Inhibitors Treatment: A Call for Caution-Authors' Reply.

Journal: Alimentary pharmacology & therapeutics

Published: December 26, 2024

PIVKA-II as a surrogate biomarker for therapeutic response in Non-AFP-secreting hepatocellular carcinoma.

PIVKA-II as a surrogate biomarker for therapeutic response in Non-AFP-secreting hepatocellular carcinoma.

Journal: BMC cancer

Published: September 30, 2024

Efficacy of atezolizumab combined with platinum and etoposide in the treatment of extrapulmonary neuroendocrine carcinoma.

Efficacy of atezolizumab combined with platinum and etoposide in the treatment of extrapulmonary neuroendocrine carcinoma.

Journal: The oncologist

Published: September 24, 2024

Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma.

Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma.

Journal: The New England journal of medicine

Published: September 16, 2024

Showing 1-12 of 76

Last Updated: 09/26/2026